20-F

NYMOX PHARMACEUTICAL CORPORATION

Company: NYMOX PHARMACEUTICAL CORP
Filed: May 8, 2001
Period of Report: December 31, 2000
Accession Number: 0000950123-01-502018

View Document ↗ View on SEC.gov ↗